Lehembre, F <br/><br/>
Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.  [electronic resource] 

 -  Oncogene  Jan 2001 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1204063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells<br/>Animals<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Carrier Proteins--antagonists & inhibitors<br/>Cell Nucleus--drug effects<br/>Cells, Cultured<br/>Co-Repressor Proteins<br/>DNA-Binding Proteins--antagonists & inhibitors<br/>Embryo, Mammalian<br/>Interferon-alpha--pharmacology<br/>Intracellular Signaling Peptides and Proteins<br/>Leukemia, Promyelocytic, Acute--genetics<br/>Mice<br/>Molecular Chaperones<br/>Neoplasm Proteins--metabolism<br/>Nuclear Proteins<br/>Oxides--pharmacology<br/>PAX3 Transcription Factor<br/>Paired Box Transcription Factors<br/>Promyelocytic Leukemia Protein<br/>Repressor Proteins--physiology<br/>SUMO-1 Protein<br/>Transcription Factors--antagonists & inhibitors<br/>Transcription, Genetic--drug effects<br/>Tumor Suppressor Proteins<br/>Ubiquitins--physiology